31A
[V. 1.] Special contributions —
Plenary lectures —
Carcinogenicity testing —
Metabolism-mediated effects —
Genomics, proteomics and gene regulation —
Embryonic stem cells —
Use of reconstituted tissues and co-cultures —
Barrier systems in vitro —
Biocompatibility of materials —
Validation of alternative methods —
Regulatory acceptance of alternative methods —
Predicting toxicity from structure —
Integrated testing and predicting human hazard —
Case studies: eye and skin irritation —
Case studies: skin sensitisation —
Haematotoxicology in vitro —
Experimental design and reduction —
Data analysis and reduction —
Reduction and regulatory testing —
Aspects of cost-benefit analysis —
Antibody production —
[v. 2.] Humane endpoints —
Eliminating vaccine testing in animals —
Validation and acceptance of new methods for biologicals —
Adverse effects: regulation and classification —
Adverse effects: recognition and assessment —
Adverse effects: alleviation and avoidance —
Refinement in experimental design and technique —
Refinement in behavioural research —
Refinement in housing and husbandry: rodents and rabbits —
Refinement in housing and husbandry: other non-rodents —
Use of animals in education and training —
Outreach to scientists on the three Rs —
Outreach to the general public on the three Rs and demonstration of training programmes —
Ethical aspects of transgenesis —
Role of ethical committees —
Animal models —
Point/counterpoint debates —
Workshops —
Closing plenary lectures.